Aya kamajuan panganyarna dina widang listrik magic pikeun pengobatan tumor otak.
Glioblastoma mangrupakeun kasakit deadly disebut "terminator" sabab tumor ieu tumuwuh pisan gancang sarta bisa mangaruhan saha wae umur, kalawan prognosis goréng.
There is currently no cure for this tumor, and treatment is difficult because glioblastomas extend the antennae into the brain instead of forming a solid mass that a doctor can target and remove. So even if the surgical resection is clean, the average time to tumor recurrence is only 6.9 months, and the average survival time is only 14.6 months. During the treatment process, resistance to traditional treatment is prone to occur. What is more frightening is that this kind of Tumors have a curse that has a nearly 100% chance of recurrence.
Prelude ka Iblis nu datang - Lalaunan Dengdekkeun Awak Anjeun
Scott Rider, 61 taun, cicing di Williamsport. Anjeunna parantos pensiunan sareng hirup sareng garwa sareng misanna, sareng gaduh incu anu saé.
Hiji poé, manéhna keur nyeuseuh sarta manggihan yén awakna sigana terus condong nepi ka asup kana tilelep pisan lalaunan ...
Anjeunna henteu terang naon anu kajantenan, tapi sababaraha dinten ka hareup, kaayaan janten langkung salah. Anjeunna mimiti ngarasa capé pisan, sanajan teu ngalakukeun nanaon, sarta capé pisan.
The family was a little worried whether it would be Alzheimer’s disease. He accompanied him to the hospital for a systematic examination. After the diagnosis, the whole family was shocked. Rider got one of the most deadly tumor utek, glioblastoma, but The predicted life can only be calculated in months, not years.
In April 2017, with the support of his family, he underwent surgery. The doctor said that at present the lesions were cut clean, but the fatality of this brain tumor is that it will definitely recur, but sooner or later the problem, so still You need to receive radiotherapy and chemotherapy as soon as possible to kill the remaining cancer cells in the body to the greatest extent and delay the recurrence as much as possible.
"Magic" médan listrik-angkat magic kambuh
Salami kémoterapi, dokter anu ngarawat Rider nyarios yén FDA ayeuna parantos nyatujuan metode perawatan énggal, terapi médan listrik, ogé katelah Optune, anu diwangun ku opat bantalan éléktroda napel dina kulit sirah pasien anu dicukur. Ieu dibangkitkeun-inténsitas low, médan listrik low-frékuénsi anu dikirimkeun ku Asép Sunandar Sunarya transduser ka lokasi tumor glioblastoma.
Electric fields can destroy rapidly dividing cancer cells, especially glioma, a type of tumor that divides rapidly.
Mr. Rider uses MRI to monitor brain tumors every other month. He said, “In the best case, it would shrink, but for me it didn’t grow anymore, it was very stable, which was very good.
Ayeuna, Rider percaya yén médan listrik kalayan "kakuatan magis" ngangkat kutukan anu ngulang deui pikeun anjeunna, sareng éta mangrupikeun "dermawan" anu nyalametkeun.
Anjeunna émut yén nalika anjeunna mimiti didiagnosis glioblastoma, dokter nyarios yén anjeunna ngan ukur hirup 18 dugi ka 24 bulan. Najan kitu, ayeuna geus 27 bulan sanggeus operasi, sarta teu aya gejala kambuh, cenah bakal salawasna maké médan listrik sangkan bisa neruskeun gawé.
Nalika Pak Rider henteu peryogi padamelan, anjeunna ngalakukeun sababaraha olahraga karesepna, sapertos ski sareng hoki. Nalika anjeunna aya di bumi, anjeunna ogé maén sareng incuna anu saé. Ieu mangrupikeun sihir terapi médan listrik. Éta ngamungkinkeun anjeun ngadalikeun sél kanker dina awak anjeun dina kaayaan kahirupan anu normal. Sél jeung jalma di sabudeureun éta boga pangaruh ngarugikeun.
Pak Rider miharep kasuksesanana bakal méré harepan ka batur. "Kuring teu boga cara pikeun ngéléhkeun tumor deadly kawas tumor otak ganas, tapi kuring bisa hirup dina cara positif."
Médan listrik terapi-FDA-disatujuan téhnologi perlakuan anyar
Optune parantos disatujuan ku FDA sareng katutupan ku seueur asuransi.
Terapi médan listrik ayeuna disatujuan ku FDA pikeun:
1. Treatment of adult patients with unresectable, locally advanced or metastatic mesothelioma (MPM), can be used with pemetrexed and platinum chemotherapy.
2. Adult patients (22 years or older) for histologically confirmed glioblastoma multiforme (GBM).
3. Gabungan temozolomide pikeun pengobatan glioblastoma karek didiagnosis di penderita sawawa.
4. Pikeun gliomas kumat sanggeus narima kémoterapi, terapi médan listrik bisa ditarima nyalira.
The use of alternating low-intensity electric fields can destroy tumor cells and reduce damage to healthy tissues, which can effectively prevent side effects from affecting patients’ quality of life. Since 2000, the R & D team has been developing and expanding indications for electric field therapy. At present, researchers are conducting clinical trials on common solid tumors, including non-small cell lung cancer, non-small cell lung cancer brain metastasis, pancreatic cancer has launched phase III clinical trials, kanker indung and mesothelioma have completed phase II clinical trials, will soon Entered Phase III trials, and liver cancer is undergoing Phase II trials. These cancers have achieved very exciting clinical data.
Medan listrik perawatan tumor Optune mangrupikeun skéma perawatan tumor énggal. Ieu mangrupikeun perlakuan anu ngagunakeun frekuensi médan listrik khusus pikeun ngaganggu pamisahan sél, ngahambat kamekaran tumor sareng nyababkeun sél kanker anu kapangaruhan ku médan listrik maot. Studi in vitro sareng in vivo parantos negeskeun yén médan listrik pengobatan tumor tiasa ngalambatkeun sareng ngabalikeun kamekaran tumor ku cara ngahambat mitosis sél tumor.
Ahli tumor otak anu kasohor Dr. Roger Stupp sakali nyarios:
"Dua puluh taun ka pengker, nalika kuring ngamimitian ngubaran glioblastoma, kalolobaan pasien maot kirang ti sataun, sareng ampir henteu aya kasus kasalametan jangka panjang. Kusabab perlakuan lapang tumor digabungkeun jeung perlakuan temozolomide, unggal 7 penderita Salah sahijina salamet leuwih ti 5 taun. “
Salaku tambahan, pangaruh terapi médan listrik tumor raket patalina sareng patuh. Nalika pasien ngagem langkung ti 22 jam sadinten, tingkat kasalametan lima taun tiasa ningkat kana 29.3%, anu ampir 6 kali tingkat kasalametan lima taun sadayana temozolomide nyalira! Anu langkung penting, metode perawatan ieu ampir teu aya efek samping anu disababkeun ku kemoradiasi. Anu paling umum nyaéta ruam dina daérah kontak pad éléktroda. Ieu unprecedented dina sajarah perlakuan tumor otak.
It is reported that Zaiding Pharmaceuticals is submitting an application for special approval of innovative medical devices to the State Drug Administration, and plans to submit an application for electric field therapy to be exempted from clinical trials. At the same time, it has completed a refinancing of US $ 200 million. Introduced Optune, a tumor electric field therapy, to start a new era of non-invasive tumor treatment! At present, you can go to Hong Kong through the Medical Department of Global Oncologist Network, and receive electric field treatment in Japan (400-666-7998)
I look forward to electric field therapy entering mainland China as soon as possible, and hope that this technology that brings huge survival benefits to cancer patients can enter medical insurance as soon as possible and bring the gospel to the majority of patients!
Rujukan: https://www.pahomepage.com/news/using-electricity-to-treat-aggressive-brain-tumor/
